Paper36450849
Blockade of CXXC5-dishevelled interaction inhibits adipogenic differentiation, obesity, and insulin resistance in mice.
Seo SH and 3 others. Sci Rep, 2022. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Blockade of CXXC5-dishevelled interaction inhibits adipogenic differentiation, obesity, and insulin resistance in mice. Papers, record 36450849. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36450849
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blockade of CXXC5-dishevelled interaction inhibits adipogenic differentiation, obesity, and insulin resistance in mice.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Insulin Resistance | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Mice | |
| Animals | |
| Adipogenesis | |
| beta Catenin | |
| Obesity | |
| DNA-Binding Proteins | |
| Transcription Factors |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28595998 | Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/28595998 | PubMed |
| 2 | 25633194 | CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation. | Cell Death Differ | 2015 | https://conductscience.org/library/papers/25633194 | PubMed |
| 3 | 35458158 | Time to Consider the "Exposome Hypothesis" in the Development of the Obesity Pandemic. | Nutrients | 2022 | https://conductscience.org/library/papers/35458158 | PubMed |
| 4 | 32158768 | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/32158768 | PubMed |
| 5 | 10757623 | One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. | Int J Obes Relat Metab Disord | 2000 | https://conductscience.org/library/papers/10757623 | PubMed |
| 6 | 15864338 | Inflammation, stress, and diabetes. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15864338 | PubMed |
| 7 | 27110066 | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. | Mediators Inflamm | 2016 | https://conductscience.org/library/papers/27110066 | PubMed |
| 8 | 27188262 | FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss. | Clin Nutr | 2017 | https://conductscience.org/library/papers/27188262 | PubMed |
| 9 | 10730683 | Orlistat, a new lipase inhibitor for the management of obesity. | Pharmacotherapy | 2000 | https://conductscience.org/library/papers/10730683 | PubMed |
| 10 | 34016596 | The Role of TCF7L2 in Type 2 Diabetes. | Diabetes | 2021 | https://conductscience.org/library/papers/34016596 | PubMed |
| 11 | 10937998 | Inhibition of adipogenesis by Wnt signaling. | Science | 2000 | https://conductscience.org/library/papers/10937998 | PubMed |
| 12 | 20220130 | A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20220130 | PubMed |
| 13 | 29027993 | Current pharmacotherapy for obesity. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/29027993 | PubMed |
| 14 | 22858652 | Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons. | Nat Rev Drug Discov | 2012 | https://conductscience.org/library/papers/22858652 | PubMed |
| 15 | 26903879 | Influencing Factors of Thermogenic Adipose Tissue Activity. | Front Physiol | 2016 | https://conductscience.org/library/papers/26903879 | PubMed |
| 16 | 19001364 | CXXC5 is a novel BMP4-regulated modulator of Wnt signaling in neural stem cells. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19001364 | PubMed |
| 17 | 15313210 | Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15313210 | PubMed |
| 18 | 33389955 | Comprehensive Review of Current and Upcoming Anti-Obesity Drugs. | Diabetes Metab J | 2020 | https://conductscience.org/library/papers/33389955 | PubMed |
| 19 | 30971423 | CXXC5 mediates growth plate senescence and is a target for enhancement of longitudinal bone growth. | Life Sci Alliance | 2019 | https://conductscience.org/library/papers/30971423 | PubMed |
| 20 | 28061687 | New Targets for Drug Treatment of Obesity. | Annu Rev Pharmacol Toxicol | 2017 | https://conductscience.org/library/papers/28061687 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39806388 | Signal integrator function of CXXC5 in Cancer. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/39806388 | PubMed |
| 39062047 | Thermogenic Fat as a New Obesity Management Tool: From Pharmaceutical Reagents to Cell Therapies. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062047 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| CXXC5 | 51523 | PubTator's text mining | https://conductscience.org/library/genes/51523 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36450849
GET https://conductscience.org/api/papers/v1/36450849/references?page=2